[Retracted] Additional Benefits Conferred by Endoscopic Sclerotherapy to Liver Cirrhosis Patients Receiving Endoscopic Variceal Ligation

Table 4

The blood pressure and heart rate among three groups before and after treatment.

Group	Before treatment			After treatment
	Systolic pressure (mmHg)	Diastolic pressure (mmHg)	Heart rate (times/min)	Systolic pressure (mmHg)	Diastolic pressure (mmHg)	Heart rate (times/min)
Ligation group (n = 45)	121.31 ± 10.14	82.04 ± 10.11	79.21 ± 10.32	120.42 ± 10.21	80.12 ± 10.27	80.11 ± 10.18
Sclerotherapy group (n = 45)	120.24 ± 10.37	81.21 ± 10.14	78.24 ± 10.54	119.21 ± 10.24	80.17 ± 10.19	79.21 ± 10.23
Combined group (n = 45)	121.58 ± 10.42	80.34 ± 10.26	78.23 ± 10.21	120.37 ± 10.36	80.28 ± 10.22	79.65 ± 10.47
t/P (ligation vs. sclerotherapy)	0.495/0.622	0.389/0.698	0.441/0.660	0.561/0.576	0.023/0.982	0.418/0.677
t/P (ligation vs. combined)	0.125/0.901	0.792/0.431	0.453/0.652	0.023/0.982	0.074/0.941	0.211/0.833
t/P (sclerotherapy vs. combined)	0.611/0.543	0.405/0.687	0.005/0.996	0.534/0.595	0.051/0.959	0.202/0.841